Role of Phosphodiesterase 5 and Cyclic GMP in Hypertension
Open Access
- 14 April 2016
- journal article
- review article
- Published by Springer Nature in Current Hypertension Reports
- Vol. 18 (5) , 1-8
Abstract
Cyclic GMP (cGMP) is a ubiquitous intracellular second messenger that mediates a wide spectrum of physiologic processes in multiple cell types within the cardiovascular and nervous systems. Synthesis of cGMP occurs either by NO-sensitive guanylyl cyclases in response to nitric oxide or by membrane-bound guanylyl cyclases in response to natriuretic peptides and has been shown to regulate blood pressure homeostasis by influencing vascular tone, sympathetic nervous system, and sodium and water handling in the kidney. Several cGMPs degrading phosphodiesterases (PDEs), including PDE1 and PDE5, play an important role in the regulation of cGMP signaling. Recent findings revealed that increased activity of cGMP-hydrolyzing PDEs contribute to the development of hypertension. In this review, we will summarize recent research findings regarding the cGMP/PDE signaling in the vasculature, the central nervous system, and the kidney which are associated with the development and maintenance of hypertension.Keywords
This publication has 71 references indexed in Scilit:
- Phosphodiesterase 5 Attenuates the Vasodilatory Response in Renovascular HypertensionPLOS ONE, 2013
- Role of Src Family Kinase in Extracellular Renal Cyclic Guanosine 3′,5′-Monophosphate- and Pressure-Induced NatriuresisHypertension, 2011
- Luminal flow regulates NO and O2−along the nephronAmerican Journal of Physiology-Renal Physiology, 2011
- Decreased cGMP Level Contributes to Increased Contraction in Arteries From Hypertensive RatsHypertension, 2011
- Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissuesNeuropharmacology, 2010
- Increased renal phosphodiesterase-5 activity mediates the blunted natriuretic response to a nitric oxide donor in the pregnant ratAmerican Journal of Physiology-Renal Physiology, 2010
- cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP ActionPharmacological Reviews, 2010
- Nitric oxide in rostral ventrolateral medulla regulates cardiac-sympathetic reflexes: role of synthase isoformsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- cGMP decreases surface NKCC2 levels in the thick ascending limb: role of phosphodiesterase 2 (PDE2)American Journal of Physiology-Renal Physiology, 2008
- Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular systemJournal of Clinical Investigation, 2006